Mundelein, IL, United States of America

Daryl E Hartter


Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1995-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Daryl E Hartter**

Introduction

Daryl E Hartter, an accomplished inventor based in Mundelein, IL, has made significant strides in the field of pharmaceuticals with his innovative inventions. Holding three patents, his work focuses primarily on developing reagents and methods for the quantification of specific antidepressant medications, showcasing his expertise and commitment to advancing medical diagnostics.

Latest Patents

Hartter's latest patents include detailed methods and reagents for the quantification of amitriptyline and nortriptyline in test samples. One patent discloses immunoassay methods employing antibodies prepared with derivatives of these compounds. Specifically, the invention provides a way to synthesize unique fluorescein tracers designed to enhance the specificity of immunoassays for detecting these tricyclic antidepressants. Another key patent addresses the challenge of determining a compound of interest in samples that may contain interfering substances with similar chemical structures. This method utilizes a pretreatment reagent to selectively modify the targeted compound, allowing for accurate analytical determination through various techniques, including immunoassays and high-pressure liquid chromatography.

Career Highlights

Daryl E Hartter has dedicated his career to advancing pharmaceutical technology, particularly while working at Abbott Laboratories Corporation. His commitment to research and development has led to groundbreaking inventions that significantly contribute to healthcare by improving drug detection methods.

Collaborations

Throughout his career, Hartter has collaborated with notable individuals such as Maciej B Adamczyk and Jeffrey R Fishpaugh. These collaborations have fostered an environment of innovation and creativity within the field, enabling advancements in diagnostic methods that benefit both practitioners and patients.

Conclusion

Daryl E Hartter's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking on healthcare solutions. His patents represent a commitment to enhancing the precision and effectiveness of drug testing, illustrating the vital role inventors play in advancing medical practices. As he continues to develop novel methods and reagents, the future of pharmaceutical diagnostics looks promising under his guidance.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…